Enhancement of antibiotic activity by efflux inhibitors against multidrug resistant mycobacterium tuberculosis clinical isolates from Brazil

Detalhes bibliográficos
Autor(a) principal: Coelho, Tatiane Silveira
Data de Publicação: 2015
Outros Autores: Machado, Diana, Couto, Isabel, Maschmann, Raquel Abreu, Soares, Daniela Fernandes Ramos, Groll, Andrea Von, Rossetti, Maria Lucia Rosa, Silva, Pedro Almeida da, Viveiros, Miguel
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FURG (RI FURG)
Texto Completo: http://repositorio.furg.br/handle/1/7019
Resumo: Drug resistant tuberculosis continues to increase and new approaches for its treatment are necessary. The identification of M. tuberculosis clinical isolates presenting efflux as part of their resistant phenotype has a major impact in tuberculosis treatment. In this work, we used a checkerboard procedure combined with the tetrazolium microplate-based assay (TEMA) to study single combinations between antituberculosis drugs and efflux inhibitors (EIs) against multidrug resistant M. tuberculosis clinical isolates using the fully susceptible strain H37Rv as reference. Efflux activity was studied on a real-time basis by a fluorometric method that uses ethidium bromide as efflux substrate. Quantification of efflux pump genes mRNA transcriptional levels were performed by RT-qPCR. The fractional inhibitory concentrations (FIC) indicated synergistic activity for the interactions between isoniazid, rifampicin, amikacin, ofloxacin, and ethidium bromide plus the EIs verapamil, thioridazine and chlorpromazine. The FICs ranged from 0.25, indicating a four-fold reduction on the MICs, to 0.015, 64-fold reduction. The detection of active efflux by real-time fluorometry showed that all strains presented intrinsic efflux activity that contributes to the overall resistance which can be inhibited in the presence of the EIs. The quantification of the mRNA levels of the most important efflux pump genes on these strains shows that they are intrinsically predisposed to expel toxic compounds as the exposure to subinhibitory concentrations of antibiotics were not necessary to increase the pump mRNA levels when compared with the non-exposed counterpart. The results obtained in this study confirm that the intrinsic efflux activity contributes to the overall resistance in multidrug resistant clinical isolates of M. tuberculosis and that the inhibition of efflux pumps by the EIs can enhance the clinical effect of antibiotics that are their substrates.
id FURG_3dec4297f0400ba67d9d22cb81ced606
oai_identifier_str oai:repositorio.furg.br:1/7019
network_acronym_str FURG
network_name_str Repositório Institucional da FURG (RI FURG)
repository_id_str
spelling Enhancement of antibiotic activity by efflux inhibitors against multidrug resistant mycobacterium tuberculosis clinical isolates from BrazilTuberculosisDrug resistanceFluorometryCheckerboardTEMAFractional inhibitory concentrationDrug resistant tuberculosis continues to increase and new approaches for its treatment are necessary. The identification of M. tuberculosis clinical isolates presenting efflux as part of their resistant phenotype has a major impact in tuberculosis treatment. In this work, we used a checkerboard procedure combined with the tetrazolium microplate-based assay (TEMA) to study single combinations between antituberculosis drugs and efflux inhibitors (EIs) against multidrug resistant M. tuberculosis clinical isolates using the fully susceptible strain H37Rv as reference. Efflux activity was studied on a real-time basis by a fluorometric method that uses ethidium bromide as efflux substrate. Quantification of efflux pump genes mRNA transcriptional levels were performed by RT-qPCR. The fractional inhibitory concentrations (FIC) indicated synergistic activity for the interactions between isoniazid, rifampicin, amikacin, ofloxacin, and ethidium bromide plus the EIs verapamil, thioridazine and chlorpromazine. The FICs ranged from 0.25, indicating a four-fold reduction on the MICs, to 0.015, 64-fold reduction. The detection of active efflux by real-time fluorometry showed that all strains presented intrinsic efflux activity that contributes to the overall resistance which can be inhibited in the presence of the EIs. The quantification of the mRNA levels of the most important efflux pump genes on these strains shows that they are intrinsically predisposed to expel toxic compounds as the exposure to subinhibitory concentrations of antibiotics were not necessary to increase the pump mRNA levels when compared with the non-exposed counterpart. The results obtained in this study confirm that the intrinsic efflux activity contributes to the overall resistance in multidrug resistant clinical isolates of M. tuberculosis and that the inhibition of efflux pumps by the EIs can enhance the clinical effect of antibiotics that are their substrates.2017-01-15T20:13:05Z2017-01-15T20:13:05Z2015info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfCOELHO, Tatiane Silveira; et al. Enhancement of antibiotic activity by efflux inhibitors against multidrug resistant mycobacterium tuberculosis clinical isolates from Brazil. Frontiers in Microbiology. V. 6, p. 330, 2015. Disponível em: <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412083/pdf/fmicb-06-00330.pdf>.Acesso em: 13 jan. 2017.http://repositorio.furg.br/handle/1/7019doi: 10.3389/fmicb.2015.00330engCoelho, Tatiane SilveiraMachado, DianaCouto, IsabelMaschmann, Raquel AbreuSoares, Daniela Fernandes RamosGroll, Andrea VonRossetti, Maria Lucia RosaSilva, Pedro Almeida daViveiros, Miguelinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FURG (RI FURG)instname:Universidade Federal do Rio Grande (FURG)instacron:FURG2022-10-21T21:59:54Zoai:repositorio.furg.br:1/7019Repositório InstitucionalPUBhttps://repositorio.furg.br/oai/request || http://200.19.254.174/oai/requestopendoar:2022-10-21T21:59:54Repositório Institucional da FURG (RI FURG) - Universidade Federal do Rio Grande (FURG)false
dc.title.none.fl_str_mv Enhancement of antibiotic activity by efflux inhibitors against multidrug resistant mycobacterium tuberculosis clinical isolates from Brazil
title Enhancement of antibiotic activity by efflux inhibitors against multidrug resistant mycobacterium tuberculosis clinical isolates from Brazil
spellingShingle Enhancement of antibiotic activity by efflux inhibitors against multidrug resistant mycobacterium tuberculosis clinical isolates from Brazil
Coelho, Tatiane Silveira
Tuberculosis
Drug resistance
Fluorometry
Checkerboard
TEMA
Fractional inhibitory concentration
title_short Enhancement of antibiotic activity by efflux inhibitors against multidrug resistant mycobacterium tuberculosis clinical isolates from Brazil
title_full Enhancement of antibiotic activity by efflux inhibitors against multidrug resistant mycobacterium tuberculosis clinical isolates from Brazil
title_fullStr Enhancement of antibiotic activity by efflux inhibitors against multidrug resistant mycobacterium tuberculosis clinical isolates from Brazil
title_full_unstemmed Enhancement of antibiotic activity by efflux inhibitors against multidrug resistant mycobacterium tuberculosis clinical isolates from Brazil
title_sort Enhancement of antibiotic activity by efflux inhibitors against multidrug resistant mycobacterium tuberculosis clinical isolates from Brazil
author Coelho, Tatiane Silveira
author_facet Coelho, Tatiane Silveira
Machado, Diana
Couto, Isabel
Maschmann, Raquel Abreu
Soares, Daniela Fernandes Ramos
Groll, Andrea Von
Rossetti, Maria Lucia Rosa
Silva, Pedro Almeida da
Viveiros, Miguel
author_role author
author2 Machado, Diana
Couto, Isabel
Maschmann, Raquel Abreu
Soares, Daniela Fernandes Ramos
Groll, Andrea Von
Rossetti, Maria Lucia Rosa
Silva, Pedro Almeida da
Viveiros, Miguel
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Coelho, Tatiane Silveira
Machado, Diana
Couto, Isabel
Maschmann, Raquel Abreu
Soares, Daniela Fernandes Ramos
Groll, Andrea Von
Rossetti, Maria Lucia Rosa
Silva, Pedro Almeida da
Viveiros, Miguel
dc.subject.por.fl_str_mv Tuberculosis
Drug resistance
Fluorometry
Checkerboard
TEMA
Fractional inhibitory concentration
topic Tuberculosis
Drug resistance
Fluorometry
Checkerboard
TEMA
Fractional inhibitory concentration
description Drug resistant tuberculosis continues to increase and new approaches for its treatment are necessary. The identification of M. tuberculosis clinical isolates presenting efflux as part of their resistant phenotype has a major impact in tuberculosis treatment. In this work, we used a checkerboard procedure combined with the tetrazolium microplate-based assay (TEMA) to study single combinations between antituberculosis drugs and efflux inhibitors (EIs) against multidrug resistant M. tuberculosis clinical isolates using the fully susceptible strain H37Rv as reference. Efflux activity was studied on a real-time basis by a fluorometric method that uses ethidium bromide as efflux substrate. Quantification of efflux pump genes mRNA transcriptional levels were performed by RT-qPCR. The fractional inhibitory concentrations (FIC) indicated synergistic activity for the interactions between isoniazid, rifampicin, amikacin, ofloxacin, and ethidium bromide plus the EIs verapamil, thioridazine and chlorpromazine. The FICs ranged from 0.25, indicating a four-fold reduction on the MICs, to 0.015, 64-fold reduction. The detection of active efflux by real-time fluorometry showed that all strains presented intrinsic efflux activity that contributes to the overall resistance which can be inhibited in the presence of the EIs. The quantification of the mRNA levels of the most important efflux pump genes on these strains shows that they are intrinsically predisposed to expel toxic compounds as the exposure to subinhibitory concentrations of antibiotics were not necessary to increase the pump mRNA levels when compared with the non-exposed counterpart. The results obtained in this study confirm that the intrinsic efflux activity contributes to the overall resistance in multidrug resistant clinical isolates of M. tuberculosis and that the inhibition of efflux pumps by the EIs can enhance the clinical effect of antibiotics that are their substrates.
publishDate 2015
dc.date.none.fl_str_mv 2015
2017-01-15T20:13:05Z
2017-01-15T20:13:05Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv COELHO, Tatiane Silveira; et al. Enhancement of antibiotic activity by efflux inhibitors against multidrug resistant mycobacterium tuberculosis clinical isolates from Brazil. Frontiers in Microbiology. V. 6, p. 330, 2015. Disponível em: <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412083/pdf/fmicb-06-00330.pdf>.Acesso em: 13 jan. 2017.
http://repositorio.furg.br/handle/1/7019
doi: 10.3389/fmicb.2015.00330
identifier_str_mv COELHO, Tatiane Silveira; et al. Enhancement of antibiotic activity by efflux inhibitors against multidrug resistant mycobacterium tuberculosis clinical isolates from Brazil. Frontiers in Microbiology. V. 6, p. 330, 2015. Disponível em: <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412083/pdf/fmicb-06-00330.pdf>.Acesso em: 13 jan. 2017.
doi: 10.3389/fmicb.2015.00330
url http://repositorio.furg.br/handle/1/7019
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Institucional da FURG (RI FURG)
instname:Universidade Federal do Rio Grande (FURG)
instacron:FURG
instname_str Universidade Federal do Rio Grande (FURG)
instacron_str FURG
institution FURG
reponame_str Repositório Institucional da FURG (RI FURG)
collection Repositório Institucional da FURG (RI FURG)
repository.name.fl_str_mv Repositório Institucional da FURG (RI FURG) - Universidade Federal do Rio Grande (FURG)
repository.mail.fl_str_mv
_version_ 1807384375239639040